Biotech Values

[microcapfun]

Nexavar for macular degeneration??

>>Avastin is a biologic approved for metastatic colorectal cancer and nonsmall cell lung cancer. Onyx will have data on its phase three trial of Nexavar for lung cancer in 2008. If Nexavar is approved for that disease, the two could compete, Liang says.

"It's possible Nexavar could supersede Avastin because an oral drug is more convenient to take," he said.

LOOKING AHEAD

Onyx will also have phase three data on Nexavar's effects on metastatic melanoma in 2008.

The company will look for noncancer uses as well, Renton says. One could be wet macular degeneration, which some doctors treat with Avastin.<<

http://money.cnn.com/news/newsfeeds/articles/newstex/IBD-0001-21352169.htm

How does having a small molecule drug help in the case of macular degeneration? You don't want to treat MD systemically, do you??

micro